Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Global save search
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
MRKR | $4.25 3.65% 3.52% 15K
|
Consumer Services
|
| O: -5.73%
H: 5.86%
C: 2.17%
hope city global medical therapeutics study
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
OCEA | $1.76 -6.13% -6.53% 200K
|
|
| O: 0.49%
H: 0.0%
C: -7.23%
global immunotherapy
Global Ginger Market Analysis Report 2023-2030: Versatility Expands Across Industries, Exploring Therapeutic Applications, Potential in Skincare and Pharmaceuticals
Published: 2024-03-27 (Crawled : 09:00) - prnewswire.com
MEDE | News | $0.51 0% 500
|
n/a
| Email alert
Add to watchlist
report pharmaceuticals global potential market
Global Mofy Metaverse Explores Partnership to Integrate Metaverse and AI Technology with Traditional Chinese and Western Therapeutic Practices
Published: 2024-03-25 (Crawled : 12:30) - globenewswire.com
GMM | $0.88 0.0% 120K
|
|
| O: -4.56%
H: 19.91%
C: 17.58%
partnership global chinese metaverse technology
Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
COMS | $0.2595 37.35% 720
|
Manufacturing
|
| O: -2.27%
H: 27.46%
C: 15.87%
WTER | $0.0015 14185.71% 640
|
Consumer Non-Durables
|
| O: 0.0%
H: 614.29%
C: 0.0%
NDAQ | $60.35 0.47% 0.46% 3.1M
|
Finance
|
| O: 0.46%
H: 3.09%
C: 1.11%
CETX | $3.06 -3.56% 2.7K
|
Electronic Technology
|
| O: 0.22%
H: 1.85%
C: -2.22%
water company international spac pharmaceuticals global system medical therapeutics market
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
Published: 2024-03-12 (Crawled : 12:30) - globenewswire.com
ALLO | $3.48 0.58% 0.57% 2M
|
Health Technology
|
| O: -0.39%
H: 1.78%
C: -3.16%
disease biotechnologies global therapeutics agreement platform
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
GPCR 4 | $36.43 0.69% 0.69% 380K
|
n/a
| Email alert
Add to watchlist
conference biopharma global therapeutics
Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-03-08 (Crawled : 12:00) - globenewswire.com
CLDX | $37.98 -1.43% -1.45% 590K
|
Health Technology
|
| O: 1.53%
H: 4.13%
C: 0.48%
conference biopharma global therapeutics
Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Published: 2024-03-06 (Crawled : 21:00) - globenewswire.com
LRMR | $6.53 2.35% 2.3% 510K
|
Health Technology
|
| O: -0.44%
H: 2.77%
C: -2.41%
conference biopharma global therapeutics
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
Published: 2024-03-06 (Crawled : 21:00) - prnewswire.com
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 2.26%
H: 18.38%
C: 12.5%
biopharma global
Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
Published: 2024-03-06 (Crawled : 13:30) - werewolftx.com
HOWL | $5.91 0.68% 0.68% 120K
|
Professional, Scientific, and T...
|
| O: 2.05%
H: 2.87%
C: 0.86%
conference biopharma global therapeutics
Edgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024
Published: 2024-03-05 (Crawled : 17:00) - biospace.com/
EWTX | $15.23 -1.42% -1.44% 540K
|
Manufacturing
|
| O: -0.76%
H: 4.51%
C: 0.59%
conference biopharma global therapeutics
Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-03-05 (Crawled : 17:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: -0.94%
H: 1.8%
C: -4.03%
conference biopharma global therapeutics
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
KROS | $58.345 -1.03% -1.04% 350K
|
Health Technology
|
| O: -3.38%
H: 4.02%
C: 0.24%
conference biopharma global therapeutics
Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -3.0%
H: 3.73%
C: -0.27%
conference biopharma global therapeutics
Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-03-05 (Crawled : 12:30) - prnewswire.com
RLMD | $4.0 -6.98% -7.5% 150K
|
Health Technology
|
| O: -1.26%
H: 3.51%
C: 0.8%
conference biopharma global therapeutics
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 12:30) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.19%
H: 1.76%
C: 0.66%
conference corporation biopharma global therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770
|
Finance
MGOL 4 | $0.229 -4.18% 13.72% 420K
|
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
MGLD 4 | $1.23 8.85% 7.32% 14K
|
Manufacturing
GRFX | $0.2116 -1.58% 7.28% 40K
|
n/a
COMP | $3.24 -0.61% 6.48% 2.4M
|
LYT | $4.22 4.72% 5.62% 1.4M
|
Your saved searches
Save your searches and get alerts when important news are released.